| Metric | FY 2025↕ | FY 2024↕ | FY 2022↕ |
|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.1B |
| Cost of Revenue | — | $0.8B | $0.7B |
| Gross Profit | — | $0.3B | $0.3B |
| R&D Expense | — | — | — |
| SG&A Expense | $0.1B | $0.2B | $0.1B |
| Operating Income | $0.1B | $0.1B | $0.2B |
| Net Income | $-0.0B | $-0.1B | $0.1B |
| EPS (Basic) | $-0.13 | $-0.61 | $0.32 |
| EPS (Diluted) | $-0.13 | $-0.61 | $0.30 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2022↕ |
|---|---|---|---|
| Total Assets | $3.2B | $3.1B | $2.8B |
| Current Assets | $0.1B | $0.1B | $0.2B |
| Cash & Equivalents | — | — | — |
| Total Liabilities | $3.3B | $3.2B | $2.5B |
| Current Liabilities | $0.2B | $0.2B | $0.2B |
| Stockholders' Equity | $-0.3B | $-0.2B | $0.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2022↕ |
|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.2B | $-0.4B | $-0.3B |
| Capital Expenditures | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $0.0B | $0.1B | $0.1B |